The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(6-(Furo[3,2-c]pyridin-4-ylamino)pyridin-3-yl)-1,5-dimethylpyrimidine-2,4(1H,3H)-dione ID: ALA4538358
PubChem CID: 155549423
Max Phase: Preclinical
Molecular Formula: C18H15N5O3
Molecular Weight: 349.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(-c2ccc(Nc3nccc4occc34)nc2)n(C)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C18H15N5O3/c1-10-15(23(2)18(25)22-17(10)24)11-3-4-14(20-9-11)21-16-12-6-8-26-13(12)5-7-19-16/h3-9H,1-2H3,(H,19,20,21)(H,22,24,25)
Standard InChI Key: LOUGEFVASUWEKZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
40.3753 -20.9993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.3741 -21.8188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0822 -22.2278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7918 -21.8184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7890 -20.9957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0804 -20.5904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4926 -20.5845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2017 -20.9926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.9058 -20.5849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9069 -19.7673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.1978 -19.3592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4876 -19.7686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6661 -22.2269 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.7788 -19.3620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1975 -18.5420 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.6135 -20.9935 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.2028 -21.8098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6654 -23.0441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6642 -24.6770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3746 -24.2645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3721 -23.4494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9530 -24.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9532 -23.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1735 -23.1975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6914 -23.8607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1732 -24.5240 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 12 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
5 7 1 0
2 13 1 0
12 14 1 0
11 15 2 0
9 16 2 0
8 17 1 0
13 18 1 0
18 23 2 0
22 19 2 0
19 20 1 0
20 21 2 0
21 18 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.35Molecular Weight (Monoisotopic): 349.1175AlogP: 2.33#Rotatable Bonds: 3Polar Surface Area: 105.81Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.98CX Basic pKa: 3.72CX LogP: 1.41CX LogD: 1.41Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.59Np Likeness Score: -0.83
References 1. Wang P, Felsing DE, Chen H, Raval SR, Allen JA, Zhou J.. (2019) Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists., 10 (5): [PMID:31098001 ] [10.1021/acsmedchemlett.9b00050 ]